We are live on
!
Find out more
VW
Vantage Wealth Portfolio holdings
AUM
$463M
1-Year Est. Return
18.98%
This Fund
S&P 500
This Quarter
Est. Return
+1.15%
1 Year Est. Return
+18.98%
3 Year Est. Return
+56.09%
5 Year Est. Return
+73.82%
10 Year Est. Return
+250.43%
AUM
$157M
AUM Growth
-$589K
(-0.37%)
Cap. Flow
-$3.15M
Cap. Flow
% of AUM
-2%
Top 10 Holdings %
Top 10 Hldgs %
54.1%
Holding
22
New
1
Increased
13
Reduced
6
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$6.87M |
| 2 |
Biogen
BIIB
|
+$1.88M |
| 3 |
JPMorgan Chase
JPM
|
+$208K |
| 4 |
Microsoft
MSFT
|
+$170K |
| 5 |
T. Rowe Price
TROW
|
+$142K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$7.47M |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$4.31M |
| 3 |
3M
MMM
|
+$1.01M |
| 4 |
Johnson & Johnson
JNJ
|
+$318K |
| 5 |
Qualcomm
QCOM
|
+$252K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.79% |
| 2 | Industrials | 18.84% |
| 3 | Healthcare | 15.78% |
| 4 | Technology | 15.36% |
| 5 | Consumer Staples | 9.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Qualcomm
QCOM
$156B
| $9.36M | 5.96% |
174,725
-4,775
| -3% | -$252K |
|
2
Novartis
NVS
$297B
| $9.31M | 5.93% |
125,987
-1,967
| -2% | -$136K |
|
3
Berkshire Hathaway Class B
BRK.B
$1.1T
| $9M | 5.73% |
62,171
+775
| +1% | +$111K |
|
|
4
Johnson & Johnson
JNJ
$622B
| $8.43M | 5.37% |
69,511
-2,800
| -4% | -$318K |
|
5
PepsiCo
PEP
$191B
| $8.38M | 5.33% |
79,085
-365
| -0.5% | -$37.7K |
|
|
6
JPMorgan Chase
JPM
$941B
| $8.25M | 5.25% |
132,774
+3,325
| +3% | +$208K |
|
7
Visa
V
$679B
| $8.16M | 5.19% |
109,959
+1,600
| +1% | +$125K |
|
8
Apple
AAPL
$4.44T
| $7.78M | 4.95% |
325,524
+1,820
| +0.6% | +$45.2K |
|
9
RTX Corp
RTX
$289B
| $7.57M | 4.82% |
117,308
+1,827
| +2% | +$117K |
|
10
United Parcel Service
UPS
$88.9B
| $7.35M | 4.68% |
68,203
+1,105
| +2% | +$115K |
|
11
Canadian National Railway
CNI
$77.3B
| $7.34M | 4.67% |
124,300
+2,115
| +2% | +$128K |
|
|
12
3M
MMM
$90.8B
| $7.34M | 4.67% |
50,121
-7,182
| -13% | -$1.01M |
|
13
Colgate-Palmolive
CL
$73.1B
| $7.15M | 4.55% |
97,674
-225
| -0.2% | -$16K |
|
|
14
Biogen
BIIB
$30.2B
| $7.04M | 4.48% |
29,126
+7,131
| +32% | +$1.88M |
|
|
15
Microsoft
MSFT
$3.39T
| $7M | 4.45% |
136,766
+3,275
| +2% | +$170K |
|
|
16
T. Rowe Price
TROW
$24.1B
| $6.88M | 4.38% |
94,240
+1,910
| +2% | +$142K |
|
|
17
Wells Fargo
WFC
$261B
| $6.67M | 4.25% |
+140,975
| New | +$6.87M |
|
|
18
Accenture
ACN
$99.4B
| – | – |
-64,729
| Closed | -$7.47M |
|
|
VXX
19
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| – | – |
-15,288
| Closed | -$4.31M |
|
Similar funds
CAM
CIP
MG
VFPW
HFA
STS
KK
GFA
Vantage Wealth's Q2 2016 Portfolio in Review
As of Q2 2016, Vantage Wealth held 22 positions worth $157M, down 0.37% from $158M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Vantage Wealth's Q2 2016 filing shows 1 new, 13 increased, 6 reduced and 2 closed positions. Its largest new stake was Wells Fargo: 140,975 shares worth $6.67M. The largest sale was Accenture, an estimated $7.47M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
- Vantage Wealth's largest Q2 2016 buy was Wells Fargo: 140,975 shares worth $6.67M.
- Vantage Wealth added most to Biogen in Q2 2016, an estimated $1.88M increase.
- Vantage Wealth's biggest Q2 2016 reduction was 3M, cutting an estimated $1.01M.
- Vantage Wealth fully exited Accenture in Q2 2016, selling an estimated $7.47M.
- Vantage Wealth's ten largest holdings make up 54% of its $157M portfolio in Q2 2016.
- Vantage Wealth opened 1 new position and closed 2 in Q2 2016.
- Vantage Wealth's portfolio value fell 0.37% quarter-over-quarter to $157M.
Based on Vantage Wealth's 13F filing for Q2 2016, filed 10 Aug 2016.